NEW
Stock Screener with Intrinsic Value
Novo Nordisk A/S (NVO)
Last Price$86.30.8%
Market Cap$384.7B
26.2%
Peers median - 14.5%
24.9%
Peers median - 0.6%
47.3%
Peers median - 7.9%
42.9%
Peers median - (18.0%)
Competing with NVO
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare NVO Valuation Multiples with Peers
Crunching data... Almost there!
Compare NVO Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Novo Nordisk A/S (NVO) revenue growth compare to peers and the industry?
Novo Nordisk A/S (NVO) revenue growth is 26.2%, compared to the peers' median of 14.5%.
2. How does Novo Nordisk A/S (NVO) Free Cash Flow (FCF) margin compare to peers and the industry?
Novo Nordisk A/S (NVO) FCF margin is 24.9%, compared to the peers' median of 0.6%.
3. How does Novo Nordisk A/S (NVO) Total Debt to Equity ratio compare to peers and the industry?
Novo Nordisk A/S (NVO) Total Debt to Equity ratio is 47.3%, compared to the peers' median of 7.9%.
4. How does Novo Nordisk A/S (NVO) ROIC (Return on Invested Capital) compare to peers and the industry?
Novo Nordisk A/S (NVO) ROIC is 42.9%, compared to the peers' median of (18.0%).